SLEDAI, SLE disease activity index

Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study
M B Urowitz, D D Gladman, D Ibanez, Y Berliner

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 115-117; DOI: 10.1136/ard.2005.038802
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity
G Zandman-Goddard, M Blank, P Langevitz, L Slutsky, M Pras, Y Levy, O Shovman, T Witte, A Doria, J Rovensky, Y Shoenfeld

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1698-1702; DOI: 10.1136/ard.2005.035832
Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus
E S Husebye, Z M Sthoeger, M Dayan, H Zinger, D Elbirt, M Levite, E Mozes

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1210-1213; DOI: 10.1136/ard.2004.029280
Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems
P Härle, R H Straub, R Wiest, A Mayer, J Schölmerich, F Atzeni, M Carrabba, M Cutolo, P Sarzi-Puttini

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 51-56; DOI: 10.1136/ard.2005.038059
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus
Jérémie Sellam, Corinne Miceli-Richard, Jacques-Eric Gottenberg, Marc Ittah, Frédéric Lavie, Christine Lacabaratz, Nicolas Gestermann, Alexis Proust, Olivier Lambotte, Xavier Mariette

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 790-797; DOI: 10.1136/ard.2006.065656
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
W Stohl, S Metyas, S-M Tan, G S Cheema, B Oamar, V Roschke, Y Wu, K P Baker, D M Hilbert

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1096-1103; DOI: 10.1136/ard.2003.018663
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
L Barile-Fabris, R Ariza-Andraca, L Olguín-Ortega, L J Jara, A Fraga-Mouret, J M Miranda-Limón, J Fuentes de la Mata, P Clark, F Vargas, J Alocer-Varela

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 620-625; DOI: 10.1136/ard.2004.025528
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
A Holvast, A Huckriede, J Wilschut, G Horst, J J C De Vries, C A Benne, C G M Kallenberg, M Bijl

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 913-918; DOI: 10.1136/ard.2005.043943
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis
T J A Lehman, B S Edelheit, K B Onel

Annals of the Rheumatic Diseases Mar 2004, 63 (3) 321-323; DOI: 10.1136/ard.2003.008342
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone
Cecile Grootscholten, Jürgen W C Dieker, Fabian D McGrath, Anja Roos, Ronald H W M Derksen, Johan van der Vlag, Mohamed R Daha, Jo H M Berden

Annals of the Rheumatic Diseases May 2007, 66 (5) 693-696; DOI: 10.1136/ard.2006.065425

Log in using your username and password

Main menu

Log in using your username and password

You are here

SLEDAI, SLE disease activity index